Cargando…
Sonazoid™ versus SonoVue(®) for Diagnosing Hepatocellular Carcinoma Using Contrast-Enhanced Ultrasound in At-Risk Individuals: A Prospective, Single-Center, Intraindividual, Noninferiority Study
OBJECTIVE: To determine whether Sonazoid-enhanced ultrasound (SZUS) was noninferior to SonoVue-enhanced ultrasound (SVUS) in diagnosing hepatocellular carcinoma (HCC) using the same diagnostic criteria. MATERIALS AND METHODS: This prospective, single-center, noninferiority study (NCT04847726) enroll...
Autores principales: | Kang, Hyo-Jin, Lee, Jeong Min, Yoon, Jeong Hee, Yoo, Jeongin, Choi, Yunhee, Joo, Ijin, Han, Joon Koo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Radiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614293/ https://www.ncbi.nlm.nih.gov/pubmed/36196767 http://dx.doi.org/10.3348/kjr.2022.0388 |
Ejemplares similares
-
Head-to-head comparison of Sonazoid and SonoVue in the diagnosis of hepatocellular carcinoma for patients at high risk
por: Huang, Jiayan, et al.
Publicado: (2023) -
Contrast-enhanced ultrasonography of the liver using SonoVue
por: Ferraioli, Giovanna, et al.
Publicado: (2018) -
Prospective assessment of diagnostic efficacy and safety of Sonazoid(TM) and SonoVue(®) ultrasound contrast agents in patients with focal liver lesions
por: Lv, Ke, et al.
Publicado: (2021) -
SonoVue(®) vs. Sonazoid™ vs. Optison™: Which Bubble Is Best for Low-Intensity Sonoporation of Pancreatic Ductal Adenocarcinoma?
por: Kotopoulis, Spiros, et al.
Publicado: (2022) -
The Effect of Contrast Medium SonoVue(®) on the Electric Charge Density of Blood Cells
por: Petelska, Aneta D., et al.
Publicado: (2011)